{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:18:46Z","timestamp":1791065926282,"version":"4.1.0"},"reference-count":154,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"National Institute of Health","award":["NIH 5-T32-AR-007442-25"],"award-info":[{"award-number":["NIH 5-T32-AR-007442-25"]}]},{"name":"National Institute of Health","award":["NIH AI-042334"],"award-info":[{"award-number":["NIH AI-042334"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.2217\/imt.12.26","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T15:55:11Z","timestamp":1334764511000},"page":"425-441","source":"Crossref","is-referenced-by-count":80,"title":["Particle-Mediated Delivery of Cytokines for Immunotherapy"],"prefix":"10.1080","volume":"4","author":[{"given":"David A","family":"Christian","sequence":"first","affiliation":[{"name":"Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"issue":"3","key":"e_1_3_2_3_1_1","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.","volume":"3","author":"Atkins MB","year":"1997","unstructured":"Atkins MB , RobertsonMJ, GordonM et al. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin. Cancer Res. 3(3) , 409\u2013417 (1997).","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"e_1_3_2_3_2_1","first-page":"1081","volume":"70","author":"Bennett CL","year":"1986","unstructured":"Bennett CL , VogelzangNJ, RatainMJ, ReichSD. Hyponatremia and other toxic effects during a Phase I trial of recombinant human gamma interferon and vinblastine. Cancer Treat. Rep.70(9) , 1081\u20131084 (1986).","journal-title":"Cancer Treat. Rep."},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/019262339902700112"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5238.908.a"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704093161501"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197609302951406"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197609232951305"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1632"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/252252a0"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90120-5"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-3659(96)01355-7"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2011.558081"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/08982100902726820"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmat2960"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr564"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-011-1003-3"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyr021"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLC.2010.n.101"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.7.11.1723"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0213"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.2217\/17435889.1.3.297"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2008.09.025"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc00034a002"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/263797a0"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.progpolymsci.2007.04.001"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2011.03.023"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017642"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000768"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2011.02.004"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016063109373"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1039\/b706939a"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026498209874"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982543"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2006.26.593"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21596"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10007"},{"issue":"2","key":"e_1_3_2_3_38_1","first-page":"495","volume":"41","author":"Fidler IJ","year":"1981","unstructured":"Fidler IJ , RazA, FoglerWE, HoyerLC, PosteG. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes. Cancer Res.41(2) , 495\u2013504 (1981).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110970"},{"issue":"3","key":"e_1_3_2_3_40_1","first-page":"881","volume":"39","author":"Poste G","year":"1979","unstructured":"Poste G , KirshR, FoglerWE, FidlerIJ. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res.39(3) , 881\u2013892 (1979).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.124.5.2197"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6426057"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.135.1.684"},{"key":"e_1_3_2_3_44_1","first-page":"6188","article-title":"Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.","volume":"45","author":"Saiki I","year":"1985","unstructured":"Saiki I , SoneS, FoglerWE et al. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes. Cancer Res. 45(12 Pt 1) , 6188\u20136193 (1985).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.11.3688"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(95)00027-G"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(00)00174-8"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/1520-6017(200012)89:12<1605::AID-JPS12>3.0.CO;2-R"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.143.4.1192"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1983.3.161"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1981.1.495"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199102000-00003"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/1043-4666(94)90069-8"},{"issue":"4","key":"e_1_3_2_3_54_1","first-page":"355","article-title":"Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line.","volume":"9","author":"Shin DM","year":"1990","unstructured":"Shin DM , FidlerIJ, BucanaCD et al. Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line. J. Biol. Response Mod. 9(4) , 355\u2013360 (1990).","journal-title":"J. Biol. Response Mod."},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/1043-4666(94)90014-0"},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0890-755"},{"key":"e_1_3_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/js960480l"},{"key":"e_1_3_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.07.029"},{"key":"e_1_3_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(96)01471-X"},{"key":"e_1_3_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(03)00019-8"},{"key":"e_1_3_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2004.19.764"},{"key":"e_1_3_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20009"},{"key":"e_1_3_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc0501810"},{"key":"e_1_3_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199207000-00003"},{"key":"e_1_3_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200001000-00016"},{"key":"e_1_3_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199705000-00003"},{"key":"e_1_3_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<901::AID-IJC17>3.0.CO;2-3"},{"key":"e_1_3_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686225"},{"key":"e_1_3_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.41.2.575-582.1982"},{"key":"e_1_3_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018955708443"},{"key":"e_1_3_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012176823155"},{"key":"e_1_3_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-4666(03)00267-9"},{"key":"e_1_3_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1996.270.2.C429"},{"key":"e_1_3_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1982.2.117"},{"issue":"12","key":"e_1_3_2_3_75_1","first-page":"4460","article-title":"Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.","volume":"40","author":"Fidler IJ","year":"1980","unstructured":"Fidler IJ , RazA, FoglerWE et al. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res. 40(12) , 4460\u20134466 (1980).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(80)90440-2"},{"issue":"2","key":"e_1_3_2_3_77_1","first-page":"375","article-title":"Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats.","volume":"50","author":"Debs RJ","year":"1990","unstructured":"Debs RJ , FuchsHJ, PhilipR et al. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats. Cancer Res. 50(2) , 375\u2013380 (1990).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.135.6.4289"},{"key":"e_1_3_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1989.9.591"},{"key":"e_1_3_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1991.11.177"},{"key":"e_1_3_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2000.0775"},{"key":"e_1_3_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7384789"},{"issue":"2","key":"e_1_3_2_3_83_1","first-page":"496","article-title":"Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.","volume":"42","author":"Fidler IJ","year":"1982","unstructured":"Fidler IJ , BarnesZ, FoglerWE et al. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res. 42(2) , 496\u2013501 (1982).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.133.1.515"},{"key":"e_1_3_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02175099"},{"key":"e_1_3_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00133480"},{"issue":"8","key":"e_1_3_2_3_87_1","first-page":"2127","article-title":"Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis.","volume":"51","author":"Loeffler CM","year":"1991","unstructured":"Loeffler CM , PlattJL, AndersonPM et al. Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis. Cancer Res. 51(8) , 2127\u20132132 (1991).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_88_1","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-100102262"},{"key":"e_1_3_2_3_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(95)00832-2"},{"key":"e_1_3_2_3_90_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00890-06"},{"key":"e_1_3_2_3_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.2.385"},{"key":"e_1_3_2_3_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01877424"},{"key":"e_1_3_2_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(99)00248-5"},{"key":"e_1_3_2_3_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(00)00410-9"},{"key":"e_1_3_2_3_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1578"},{"key":"e_1_3_2_3_96_1","doi-asserted-by":"publisher","DOI":"10.1089\/107999001753289497"},{"key":"e_1_3_2_3_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199408000-00005"},{"issue":"1","key":"e_1_3_2_3_98_1","first-page":"114","volume":"288","author":"Postma NS","year":"1999","unstructured":"Postma NS , CrommelinDJ, ElingWM, ZuidemaJ. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice. J. Pharmacol. Exp. Ther.288(1) , 114\u2013120 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"24","key":"e_1_3_2_3_99_1","first-page":"5841","article-title":"Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design.","volume":"53","author":"Golumbek PT","year":"1993","unstructured":"Golumbek PT , AzhariR, JaffeeEM et al. Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design. Cancer Res. 53(24) , 5841\u20135844 (1993).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00039-3"},{"key":"e_1_3_2_3_101_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007514424253"},{"key":"e_1_3_2_3_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-005-0013-x"},{"issue":"8","key":"e_1_3_2_3_103_1","first-page":"1881","article-title":"Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells.","volume":"4","author":"Koppenhagen FJ","year":"1998","unstructured":"Koppenhagen FJ , KupcuZ, WallnerG et al. Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells. Clin. Cancer Res. 4(8) , 1881\u20131886 (1998).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_3_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199911000-00007"},{"key":"e_1_3_2_3_105_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.8.3637"},{"key":"e_1_3_2_3_106_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-039446"},{"key":"e_1_3_2_3_107_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1071"},{"key":"e_1_3_2_3_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-063594"},{"issue":"6","key":"e_1_3_2_3_109_1","first-page":"1853","article-title":"Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastases.","volume":"50","author":"Anderson PM","year":"1990","unstructured":"Anderson PM , KatsanisE, LeonardAS et al. Increased local antitumor effects of interleukin 2 liposomes in mice with MCA-106 sarcoma pulmonary metastases. Cancer Res. 50(6) , 1853\u20131856 (1990).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02171684"},{"key":"e_1_3_2_3_111_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010963307097"},{"key":"e_1_3_2_3_112_1","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000053211.39087.D1"},{"key":"e_1_3_2_3_113_1","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2001.0963"},{"issue":"14","key":"e_1_3_2_3_114_1","first-page":"3832","volume":"60","author":"Egilmez NK","year":"2000","unstructured":"Egilmez NK , JongYS, SabelMS et al. In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res.60(14) , 3832\u20133837 (2000).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_115_1","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2001.115839"},{"issue":"24","key":"e_1_3_2_3_116_1","first-page":"7254","volume":"62","author":"Hill HC","year":"2002","unstructured":"Hill HC , ConwayTF Jr, Sabel MS et al. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Cancer Res.62(24) , 7254\u20137263 (2002).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_117_1","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2004.03.022"},{"key":"e_1_3_2_3_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20572"},{"key":"e_1_3_2_3_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.05.008"},{"key":"e_1_3_2_3_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0570-3"},{"key":"e_1_3_2_3_121_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050455"},{"key":"e_1_3_2_3_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200003000-00003"},{"key":"e_1_3_2_3_123_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.400"},{"key":"e_1_3_2_3_124_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.2.898"},{"key":"e_1_3_2_3_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.03.516"},{"key":"e_1_3_2_3_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90158-G"},{"key":"e_1_3_2_3_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-1981(01)00092-0"},{"key":"e_1_3_2_3_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)80005-9"},{"key":"e_1_3_2_3_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90265-Y"},{"key":"e_1_3_2_3_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00396-1"},{"key":"e_1_3_2_3_131_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.1995.11.921"},{"key":"e_1_3_2_3_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636486"},{"key":"e_1_3_2_3_133_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101400"},{"key":"e_1_3_2_3_134_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7904381"},{"key":"e_1_3_2_3_135_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8097337"},{"key":"e_1_3_2_3_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00111-4"},{"key":"e_1_3_2_3_137_1","doi-asserted-by":"publisher","DOI":"10.1089\/107999099313893"},{"key":"e_1_3_2_3_138_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01781-05"},{"key":"e_1_3_2_3_139_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.149.11.3719"},{"key":"e_1_3_2_3_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(97)02699-0"},{"key":"e_1_3_2_3_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00326-7"},{"key":"e_1_3_2_3_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00347-8"},{"key":"e_1_3_2_3_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(90)90093-2"},{"key":"e_1_3_2_3_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00251-2"},{"key":"e_1_3_2_3_145_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10345"},{"key":"e_1_3_2_3_146_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.11"},{"key":"e_1_3_2_3_147_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp100203a"},{"key":"e_1_3_2_3_148_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.8.9.8348"},{"key":"e_1_3_2_3_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2198"},{"key":"e_1_3_2_3_150_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041057"},{"key":"e_1_3_2_3_151_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103849"},{"key":"e_1_3_2_3_152_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2591"},{"key":"e_1_3_2_3_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3499"},{"key":"e_1_3_2_4_2_1","unstructured":"Vaccine therapy plus interleukin-2 with or without interferon alfa-2b in treating patients with stage III melanoma. http:\/\/clinicaltrials.gov\/show\/NCT00004104"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.12.26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:15:49Z","timestamp":1715969749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.12.26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":154,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.2217\/imt.12.26"],"URL":"https:\/\/doi.org\/10.2217\/imt.12.26","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}